These results above, as well as those from our present study, did indicate that the GR-Sgk1-NDRG1 pathway in ESCC could protect tumor cells from chemotherapy-induced apoptosis and mediate chemotherapy resistance. The gene discussed is NR3C1; the disease is neoplasm.